← Open Payments lookup

REBECCA JONES: Open Payments

NPI 1063623015 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$756 in 34 payments from 12 companies in 2025. Trend: 2023 $692 · 2024 $903 · 2025 $756

Food & beverage: $756
CompanyPaymentsAmount
ABBVIE INC.16$186
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$148
Neuronetics, Inc.1$97
Otsuka America Pharmaceutical, Inc.3$88
Vanda Pharmaceuticals Inc.2$67
Axsome Therapeutics, Inc.1$29
Takeda Pharmaceuticals U.S.A., Inc.1$27
Neurocrine BioSciences, Inc.1$26
Tris Pharma Inc1$25
Otsuka Pharmaceutical Development & Commercialization, Inc.1$23

Products named: VRAYLAR, CAPLYTA, REXULTI, NEUROSTAR TMS THERAPY SYSTEM, FANAPT, Auvelity, TRINTELLIX, INGREZZA.

Industry payments across AL — which companies pay providers there.